Chlorovirus ATCV-1 Accelerates Motor Deterioration in SOD1-G93A Transgenic Mice and Its SOD1 Augments Induction of Inflammatory Factors From Murine Macrophages
Frontiers in Neurology • 2022
Publication Information
Authors
Thomas M. Petro, Irina V. Agarkova, Ahmed Esmaelو David D. Dunigan, James L. Van Etten and Gary L. Pattee
Keywords
ALS, chlorovirus, ATCV-1, motor neuron diseases, SOD1-G93A mice
Journal
Frontiers in Neurology
Publisher
Frontiers Media SA
Volume
13
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Background: Genetically polymorphic Superoxide Dismutase 1 G93A (SOD1-G93A)
underlies one form of familial Amyotrophic Lateral Sclerosis (ALS). Exposures from
viruses may also contribute to ALS, possibly by stimulating immune factors, such
as IL-6, Interferon Stimulated Genes, and Nitric Oxide. Recently, chlorovirus ATCV-1,
which encodes a SOD1, was shown to replicate in macrophages and induce
inflammatory factors.
Objective: This study aimed to determine if ATCV-1 influences development of motor
degeneration in an ALS mouse model and to assess whether SOD1 of ATCV-1 influences
production of inflammatory factors from macrophages.
Methods: Sera from sporadic ALS patients were screened for antibody to ATCV-1.
Active or inactivated ATCV-1, saline, or a viralmimetic, polyinosinic:polycytidylic acid (poly
I:C) were injected intracranially into transgenic mice expressing human SOD1-G93A- or
C57Bl/6 mice. RAW264.7 mouse macrophage cells were transfected with a plasmid
vector expressing ATCV-1 SOD1 or an empty vector prior to stimulation with poly I:C
with or without Interferon-gamma (IFN-g).
Results: Serum from sporadic ALS patients had significantly more IgG1 antibody
directed against ATCV-1 than healthy controls. Infection of SOD1-G93A mice with
active ATCV-1 significantly accelerated onset of motor loss, as measured by tail
paralysis, hind limb tucking, righting reflex, and latency to fall in a hanging cage-lid
test, but did not significantly affect mortality when compared to saline-treated
transgenics. By contrast, poly I:C treatment significantly lengthened survival time but
only minimally slowed onset of motor loss, while heat-inactivated ATCV-1 did not
affect motor loss or survival. ATCV-1 SOD1 significantly increased expression of IL-
6, IL-10, ISG promoter activity, and production of Nitric Oxide from RAW264.7 cells.
Conclusion: ATCV-1 chlorovirus encoding an endogenous SOD1 accelerates
pathogenesis but not mortality, while poly I:C that stimulates antiviral immune responses
delays mortality in an ALS mouse model. ATCV-1 SOD1 enhances induction of
inflammatory factors from macrophages.
underlies one form of familial Amyotrophic Lateral Sclerosis (ALS). Exposures from
viruses may also contribute to ALS, possibly by stimulating immune factors, such
as IL-6, Interferon Stimulated Genes, and Nitric Oxide. Recently, chlorovirus ATCV-1,
which encodes a SOD1, was shown to replicate in macrophages and induce
inflammatory factors.
Objective: This study aimed to determine if ATCV-1 influences development of motor
degeneration in an ALS mouse model and to assess whether SOD1 of ATCV-1 influences
production of inflammatory factors from macrophages.
Methods: Sera from sporadic ALS patients were screened for antibody to ATCV-1.
Active or inactivated ATCV-1, saline, or a viralmimetic, polyinosinic:polycytidylic acid (poly
I:C) were injected intracranially into transgenic mice expressing human SOD1-G93A- or
C57Bl/6 mice. RAW264.7 mouse macrophage cells were transfected with a plasmid
vector expressing ATCV-1 SOD1 or an empty vector prior to stimulation with poly I:C
with or without Interferon-gamma (IFN-g).
Results: Serum from sporadic ALS patients had significantly more IgG1 antibody
directed against ATCV-1 than healthy controls. Infection of SOD1-G93A mice with
active ATCV-1 significantly accelerated onset of motor loss, as measured by tail
paralysis, hind limb tucking, righting reflex, and latency to fall in a hanging cage-lid
test, but did not significantly affect mortality when compared to saline-treated
transgenics. By contrast, poly I:C treatment significantly lengthened survival time but
only minimally slowed onset of motor loss, while heat-inactivated ATCV-1 did not
affect motor loss or survival. ATCV-1 SOD1 significantly increased expression of IL-
6, IL-10, ISG promoter activity, and production of Nitric Oxide from RAW264.7 cells.
Conclusion: ATCV-1 chlorovirus encoding an endogenous SOD1 accelerates
pathogenesis but not mortality, while poly I:C that stimulates antiviral immune responses
delays mortality in an ALS mouse model. ATCV-1 SOD1 enhances induction of
inflammatory factors from macrophages.
Staff Members - Benha University